# EyePoint Pharmaceuticals, Inc.

Type: Company (EYPT)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/eyepoint-pharmaceuticals-inc
Canonical HTML page: https://getbiobrief.com/entity/eyepoint-pharmaceuticals-inc

## Recent coverage (1 stories)

### Essex Woodlands Trims EyePoint Pharmaceuticals Stake to $15.45 Million
2026-02-28 00:59:04 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Essex Woodlands Management Inc. reduced its position in EyePoint Pharmaceuticals by 7.3% during the third quarter, selling 85,000 shares. Despite the reduction, the firm maintains a high-conviction $15.45 million stake, representing 5% of its total investment portfolio.
Full story: https://getbiobrief.com/story/essex-woodlands-eyepoint-pharmaceuticals-stake-reduction

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.